Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Noxafil
Active Ingredient: Posaconazole 40mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Patheon Inc, Whitby Operations, Whitby, Ontario, Canada
Product: Strepfen Intensive Orange Sugar Free
Active Ingredient: Flurbiprofen 8.75mg
Dosage Form: Lozenge
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottingham, Nottinghamshire, United Kingdom
Product: Tatig
Active Ingredient: Sertraline hydrochloride 111.9mg equivalent to 100mg sertraline
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Australia Pty Limited, West Ryde, New South Wales, Australia
Pfizer Italia Srl, Borgo San Michele, Latina, Italy
Pfizer Pharmaceuticals Limited, Economic and Technical, Development Zone, Dalian, China
Product: Tatig
Active Ingredient: Sertraline hydrochloride 55.95mg equivalent to 50mg sertraline
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Australia Pty Limited, West Ryde, New South Wales, Australia
Pfizer Italia Srl, Borgo San Michele, Latina, Italy
Pfizer Pharmaceuticals Limited, Economic and Technical, Development Zone, Dalian, China
Dated this 12th day of September 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).